27.24MMarket Cap
0.17P/E TTM
KYNB Balance Sheet
You can check out the annual or quarterly balance sheets of FibroGen Ord Shs here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing KYNB stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does FibroGen Ord Shs Have?
In its most recent quarterly, FibroGen Ord Shs had 37.00M in cash and cash equivalents.
How Much Are FibroGen Ord Shs's Total Liabilities?
FibroGen Ord Shs reported 115.12M in total liabilities as of the latest reported quarter, including 29.24M in current liabilities and 85.88M in non-current liabilities.
What Are FibroGen Ord Shs's Total Assets?
As of the latest reported quarter, FibroGen Ord Shs's total assets were 119.59M, consisting of 99.07M in current assets and 20.52M in non-current assets.
How Much Shareholders' Equity Does FibroGen Ord Shs Have?
FibroGen Ord Shs reported 4.47M in total shareholders' equity as of the latest reported quarter.